Showing results (1621-1630 of 1,945) with videos related to
Sort By:
Pageof 195
International Journal of Oncology|November 29, 2018
Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylationLaura Antonucci, Laura Di Magno, Davide D'Amico, et al.Resuscitation|July 22, 2018
Chest compression rates and pediatric in-hospital cardiac arrest survival outcomesRobert M Sutton, Ron W Reeder, William Landis, et al.Plos One|July 14, 2009
Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral bloodSunil M Kurian, Raymond Heilman, Tony S Mondala, et al.Resuscitation|August 13, 2019
Functional outcomes among survivors of pediatric in-hospital cardiac arrest are associated with baseline neurologic and functional status, but not with diastolic blood pressure during CPRHeather A Wolfe, Robert M Sutton, Ron W Reeder, et al.Neuron|August 21, 2015
The Sorting Receptor SorCS1 Regulates Trafficking of Neurexin and AMPA ReceptorsJeffrey N Savas, Luís F Ribeiro, Keimpe D Wierda, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|August 28, 2019
Survival and Cardiopulmonary Resuscitation Hemodynamics Following Cardiac Arrest in Children With Surgical Compared to Medical Heart DiseaseAndrew R Yates, Robert M Sutton, Ron W Reeder, et al.Nature Methods|March 2, 2023
Initial recommendations for performing, benchmarking and reporting single-cell proteomics experimentsLaurent Gatto, Ruedi Aebersold, Juergen Cox, et al.Nature Communications|March 12, 2024
Tissue engineered vascular grafts are resistant to the formation of dystrophic calcificationMackenzie E Turner, Kevin M Blum, Tatsuya Watanabe, et al.Resuscitation|July 5, 2020
Association between time of day and CPR quality as measured by CPR hemodynamics during pediatric in-hospital CPRHeather A Wolfe, Ryan W Morgan, Robert M Sutton, et al.Biorxiv : the Preprint Server for Biology|June 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144Sammaiah Pallerla, Shaunak Uplekar, Ferenc Boldog, et al.Pageof 195